Concepts (257)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hemorrhagic Fever, Crimean | 8 | 2019 | 118 | 3.88 | Why? |
| Hemorrhagic Fever Virus, Crimean-Congo | 7 | 2019 | 133 | 2.91 | Why? |
| Kyasanur Forest Disease | 4 | 2018 | 9 | 1.82 | Why? |
| Reoviridae Infections | 2 | 2018 | 31 | 1.46 | Why? |
| India | 38 | 2021 | 11875 | 1.13 | Why? |
| Ticks | 3 | 2019 | 107 | 1.03 | Why? |
| Orthobunyavirus | 2 | 2018 | 53 | 0.84 | Why? |
| Nipah Virus | 2 | 2019 | 121 | 0.83 | Why? |
| Henipavirus Infections | 2 | 2019 | 122 | 0.81 | Why? |
| Bunyaviridae Infections | 2 | 2018 | 107 | 0.77 | Why? |
| Encephalitis Viruses, Tick-Borne | 2 | 2019 | 100 | 0.77 | Why? |
| Orbivirus | 1 | 2018 | 5 | 0.76 | Why? |
| Reoviridae | 1 | 2018 | 26 | 0.74 | Why? |
| Chiroptera | 6 | 2020 | 3530 | 0.73 | Why? |
| Immunologic Tests | 1 | 2021 | 445 | 0.72 | Why? |
| Flavivirus | 2 | 2018 | 182 | 0.71 | Why? |
| Chikungunya Fever | 3 | 2018 | 345 | 0.70 | Why? |
| Haplorhini | 1 | 2018 | 307 | 0.69 | Why? |
| Viral Plaque Assay | 1 | 2019 | 381 | 0.67 | Why? |
| Horse Diseases | 1 | 2018 | 101 | 0.67 | Why? |
| Phylogeography | 1 | 2021 | 824 | 0.65 | Why? |
| Phlebovirus | 1 | 2017 | 106 | 0.64 | Why? |
| Culicidae | 1 | 2018 | 239 | 0.63 | Why? |
| Mosquito Vectors | 2 | 2018 | 351 | 0.61 | Why? |
| Enzyme-Linked Immunosorbent Assay | 9 | 2021 | 7868 | 0.59 | Why? |
| Genome, Viral | 8 | 2021 | 13157 | 0.53 | Why? |
| Immunoglobulin G | 9 | 2021 | 21571 | 0.46 | Why? |
| Phylogeny | 11 | 2021 | 13341 | 0.44 | Why? |
| Neutralization Tests | 5 | 2021 | 6698 | 0.44 | Why? |
| Dengue | 3 | 2018 | 1565 | 0.39 | Why? |
| Animals | 29 | 2021 | 78931 | 0.38 | Why? |
| Antibodies, Viral | 15 | 2021 | 51949 | 0.38 | Why? |
| Disease Reservoirs | 1 | 2018 | 1672 | 0.36 | Why? |
| Adipogenesis | 2 | 2017 | 38 | 0.36 | Why? |
| High-Throughput Nucleotide Sequencing | 7 | 2021 | 3633 | 0.36 | Why? |
| Transients and Migrants | 1 | 2017 | 1468 | 0.28 | Why? |
| Containment of Biohazards | 2 | 2020 | 762 | 0.24 | Why? |
| Curcumin | 2 | 2017 | 396 | 0.23 | Why? |
| Swine | 3 | 2019 | 3352 | 0.22 | Why? |
| Mesocricetus | 3 | 2021 | 1847 | 0.21 | Why? |
| Coronavirus | 2 | 2021 | 18339 | 0.21 | Why? |
| Immunoglobulin M | 2 | 2018 | 9091 | 0.21 | Why? |
| Tanzania | 1 | 2021 | 294 | 0.21 | Why? |
| Distemper Virus, Canine | 1 | 2019 | 40 | 0.20 | Why? |
| Lions | 1 | 2019 | 41 | 0.20 | Why? |
| Topography, Medical | 1 | 2019 | 45 | 0.20 | Why? |
| RNA, Viral | 7 | 2021 | 32276 | 0.20 | Why? |
| Agricultural Workers' Diseases | 1 | 2019 | 16 | 0.20 | Why? |
| Cricetinae | 4 | 2021 | 3344 | 0.20 | Why? |
| Quasispecies | 1 | 2020 | 108 | 0.19 | Why? |
| Vaccines, Inactivated | 3 | 2021 | 1562 | 0.19 | Why? |
| Transdermal Patch | 1 | 2019 | 52 | 0.19 | Why? |
| Ceratopogonidae | 1 | 2018 | 23 | 0.18 | Why? |
| Mannich Bases | 1 | 2017 | 1 | 0.18 | Why? |
| Amino Alcohols | 1 | 2017 | 7 | 0.18 | Why? |
| Coxsackievirus Infections | 1 | 2018 | 71 | 0.18 | Why? |
| Bacteriophage T4 | 1 | 2017 | 16 | 0.18 | Why? |
| Antibodies, Neutralizing | 10 | 2021 | 25288 | 0.18 | Why? |
| Thiazolidinediones | 1 | 2017 | 70 | 0.17 | Why? |
| Primates | 1 | 2021 | 584 | 0.17 | Why? |
| Mastadenovirus | 1 | 2017 | 18 | 0.17 | Why? |
| Travel | 4 | 2021 | 7220 | 0.17 | Why? |
| Animal Diseases | 1 | 2019 | 182 | 0.17 | Why? |
| Forests | 1 | 2018 | 132 | 0.16 | Why? |
| Rubella | 1 | 2018 | 127 | 0.16 | Why? |
| Humans | 51 | 2021 | 930598 | 0.16 | Why? |
| Betacoronavirus | 15 | 2020 | 204454 | 0.16 | Why? |
| Pyrazoles | 2 | 2017 | 1791 | 0.16 | Why? |
| Drug Compounding | 1 | 2019 | 386 | 0.16 | Why? |
| Vero Cells | 5 | 2020 | 14117 | 0.16 | Why? |
| Horses | 1 | 2018 | 474 | 0.16 | Why? |
| Oman | 1 | 2017 | 345 | 0.15 | Why? |
| Tick-Borne Diseases | 1 | 2016 | 68 | 0.15 | Why? |
| Laboratories | 2 | 2020 | 2858 | 0.15 | Why? |
| Sheep | 1 | 2017 | 420 | 0.15 | Why? |
| Adenoviridae Infections | 1 | 2017 | 150 | 0.15 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2021 | 13720 | 0.15 | Why? |
| Immunogenicity, Vaccine | 2 | 2021 | 4624 | 0.15 | Why? |
| Protein Structure, Tertiary | 1 | 2020 | 1565 | 0.15 | Why? |
| Mice | 7 | 2020 | 21357 | 0.14 | Why? |
| Enterovirus | 1 | 2018 | 402 | 0.14 | Why? |
| Insect Vectors | 1 | 2016 | 227 | 0.14 | Why? |
| Certification | 1 | 2017 | 261 | 0.14 | Why? |
| Encephalitis, Viral | 1 | 2018 | 355 | 0.13 | Why? |
| Endemic Diseases | 1 | 2018 | 480 | 0.13 | Why? |
| Macaca mulatta | 2 | 2021 | 3716 | 0.13 | Why? |
| Zika Virus Infection | 2 | 2018 | 1920 | 0.13 | Why? |
| Polyproteins | 1 | 2017 | 814 | 0.13 | Why? |
| Escherichia coli Infections | 1 | 2017 | 348 | 0.13 | Why? |
| Immunohistochemistry | 1 | 2021 | 2275 | 0.13 | Why? |
| Microscopy, Electron, Transmission | 3 | 2021 | 605 | 0.13 | Why? |
| Coronavirus Infections | 15 | 2021 | 253789 | 0.12 | Why? |
| Hot Temperature | 1 | 2021 | 1299 | 0.12 | Why? |
| Cholesterol | 1 | 2017 | 660 | 0.12 | Why? |
| Communicable Diseases, Imported | 1 | 2021 | 843 | 0.12 | Why? |
| Tuberculosis, Multidrug-Resistant | 1 | 2017 | 433 | 0.12 | Why? |
| Epitopes, B-Lymphocyte | 1 | 2020 | 1267 | 0.11 | Why? |
| Real-Time Polymerase Chain Reaction | 6 | 2020 | 11367 | 0.11 | Why? |
| Coinfection | 3 | 2021 | 6820 | 0.11 | Why? |
| Antitubercular Agents | 1 | 2017 | 775 | 0.11 | Why? |
| South Africa | 1 | 2021 | 3326 | 0.11 | Why? |
| Pneumonia | 2 | 2021 | 5652 | 0.11 | Why? |
| Mutation | 2 | 2021 | 12376 | 0.10 | Why? |
| Adenoviridae | 1 | 2017 | 1151 | 0.10 | Why? |
| Dyslipidemias | 1 | 2017 | 791 | 0.10 | Why? |
| Cell Line, Tumor | 1 | 2019 | 3608 | 0.10 | Why? |
| Disease Models, Animal | 4 | 2021 | 10998 | 0.10 | Why? |
| Pneumonia, Viral | 14 | 2020 | 243684 | 0.10 | Why? |
| Escherichia coli | 1 | 2017 | 1547 | 0.10 | Why? |
| Drug Delivery Systems | 1 | 2019 | 1365 | 0.09 | Why? |
| Genomics | 1 | 2021 | 3118 | 0.09 | Why? |
| Skin Absorption | 2 | 2019 | 18 | 0.09 | Why? |
| Epitopes, T-Lymphocyte | 1 | 2020 | 2262 | 0.09 | Why? |
| Adult | 15 | 2021 | 244371 | 0.09 | Why? |
| Pharynx | 3 | 2021 | 1544 | 0.09 | Why? |
| Mycobacterium tuberculosis | 1 | 2017 | 1164 | 0.09 | Why? |
| Lymphocytes | 1 | 2021 | 3056 | 0.09 | Why? |
| Administration, Cutaneous | 2 | 2019 | 229 | 0.08 | Why? |
| Point-of-Care Testing | 1 | 2021 | 2782 | 0.08 | Why? |
| Cell Cycle Checkpoints | 2 | 2017 | 126 | 0.08 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.08 | Why? |
| Male | 18 | 2021 | 367725 | 0.08 | Why? |
| Transcriptome | 1 | 2020 | 3466 | 0.08 | Why? |
| Rectum | 2 | 2021 | 495 | 0.08 | Why? |
| Disease Susceptibility | 1 | 2020 | 4002 | 0.08 | Why? |
| Survivors | 1 | 2019 | 2619 | 0.08 | Why? |
| Adolescent | 11 | 2021 | 86841 | 0.08 | Why? |
| Drug Design | 1 | 2019 | 2627 | 0.08 | Why? |
| Amides | 1 | 2017 | 1864 | 0.08 | Why? |
| Rats, Wistar | 2 | 2019 | 621 | 0.08 | Why? |
| Models, Molecular | 1 | 2020 | 7616 | 0.07 | Why? |
| Female | 17 | 2021 | 380317 | 0.07 | Why? |
| Nasal Cavity | 2 | 2021 | 909 | 0.07 | Why? |
| Disease Outbreaks | 5 | 2019 | 27595 | 0.07 | Why? |
| Genetic Variation | 1 | 2018 | 3919 | 0.07 | Why? |
| Middle Aged | 13 | 2021 | 270681 | 0.07 | Why? |
| Child | 8 | 2021 | 70012 | 0.07 | Why? |
| Follow-Up Studies | 2 | 2021 | 17020 | 0.07 | Why? |
| United Kingdom | 2 | 2021 | 18046 | 0.07 | Why? |
| Viral Load | 3 | 2021 | 15850 | 0.06 | Why? |
| Seroepidemiologic Studies | 4 | 2020 | 10017 | 0.06 | Why? |
| Genes, Viral | 2 | 2019 | 1428 | 0.06 | Why? |
| Cell Line | 1 | 2019 | 12040 | 0.06 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.06 | Why? |
| Young Adult | 10 | 2021 | 93724 | 0.06 | Why? |
| Clinical Laboratory Techniques | 4 | 2020 | 23402 | 0.05 | Why? |
| Toll-Like Receptor 8 | 1 | 2021 | 102 | 0.05 | Why? |
| Respirovirus | 1 | 2020 | 122 | 0.05 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.05 | Why? |
| Double-Blind Method | 2 | 2021 | 5988 | 0.05 | Why? |
| Simbu virus | 1 | 2018 | 5 | 0.05 | Why? |
| Passeriformes | 1 | 2018 | 14 | 0.05 | Why? |
| Amlodipine | 1 | 2019 | 45 | 0.05 | Why? |
| Turbinates | 1 | 2020 | 205 | 0.05 | Why? |
| Densovirinae | 1 | 2018 | 9 | 0.05 | Why? |
| 3T3-L1 Cells | 1 | 2017 | 29 | 0.05 | Why? |
| Drug Liberation | 1 | 2019 | 141 | 0.05 | Why? |
| Microscopy, Electron | 1 | 2021 | 830 | 0.05 | Why? |
| Time Factors | 2 | 2019 | 31397 | 0.05 | Why? |
| Ethambutol | 1 | 2017 | 34 | 0.04 | Why? |
| Adenoviruses, Human | 1 | 2020 | 195 | 0.04 | Why? |
| Influenza A virus | 2 | 2021 | 2234 | 0.04 | Why? |
| Chick Embryo | 1 | 2018 | 249 | 0.04 | Why? |
| Permeability | 1 | 2019 | 238 | 0.04 | Why? |
| Mice, Inbred BALB C | 2 | 2020 | 5814 | 0.04 | Why? |
| Excipients | 1 | 2019 | 118 | 0.04 | Why? |
| Biological Transport, Active | 1 | 2017 | 46 | 0.04 | Why? |
| Child, Preschool | 5 | 2020 | 36283 | 0.04 | Why? |
| Livestock | 1 | 2019 | 184 | 0.04 | Why? |
| Larva | 1 | 2018 | 153 | 0.04 | Why? |
| Emulsions | 1 | 2017 | 80 | 0.04 | Why? |
| 3T3 Cells | 1 | 2017 | 152 | 0.04 | Why? |
| Pandemics | 14 | 2020 | 389249 | 0.04 | Why? |
| Siblings | 1 | 2018 | 226 | 0.04 | Why? |
| Bacterial Load | 1 | 2017 | 179 | 0.04 | Why? |
| Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 382 | 0.04 | Why? |
| Metapneumovirus | 1 | 2020 | 465 | 0.04 | Why? |
| Th2 Cells | 1 | 2021 | 680 | 0.04 | Why? |
| Toll-Like Receptor 7 | 1 | 2021 | 402 | 0.04 | Why? |
| Delayed-Action Preparations | 1 | 2019 | 291 | 0.04 | Why? |
| Aged | 8 | 2021 | 215776 | 0.04 | Why? |
| Adipocytes | 1 | 2017 | 173 | 0.04 | Why? |
| Quality Control | 1 | 2020 | 628 | 0.04 | Why? |
| Serogroup | 1 | 2018 | 510 | 0.04 | Why? |
| Biological Availability | 1 | 2017 | 388 | 0.04 | Why? |
| Influenza, Human | 1 | 2021 | 10779 | 0.04 | Why? |
| Spleen | 1 | 2020 | 877 | 0.04 | Why? |
| Geography, Medical | 1 | 2018 | 537 | 0.04 | Why? |
| Calcium Channel Blockers | 1 | 2019 | 367 | 0.04 | Why? |
| Weight Loss | 1 | 2021 | 826 | 0.04 | Why? |
| Symptom Assessment | 2 | 2020 | 4967 | 0.04 | Why? |
| Trachea | 1 | 2020 | 894 | 0.04 | Why? |
| HIV Antibodies | 1 | 2021 | 776 | 0.04 | Why? |
| Public Health | 1 | 2021 | 16359 | 0.04 | Why? |
| Fomites | 1 | 2021 | 709 | 0.04 | Why? |
| Cross Infection | 1 | 2017 | 8675 | 0.04 | Why? |
| Zika Virus | 2 | 2018 | 1924 | 0.04 | Why? |
| Th1 Cells | 1 | 2021 | 1228 | 0.03 | Why? |
| Chikungunya virus | 1 | 2018 | 339 | 0.03 | Why? |
| Drug Synergism | 1 | 2017 | 833 | 0.03 | Why? |
| Polymers | 1 | 2019 | 507 | 0.03 | Why? |
| Rhinovirus | 1 | 2020 | 979 | 0.03 | Why? |
| Influenza B virus | 1 | 2020 | 815 | 0.03 | Why? |
| Reproducibility of Results | 2 | 2021 | 11304 | 0.03 | Why? |
| Sequence Alignment | 1 | 2020 | 2109 | 0.03 | Why? |
| Spatial Analysis | 1 | 2019 | 878 | 0.03 | Why? |
| Respiratory Syncytial Virus, Human | 1 | 2020 | 846 | 0.03 | Why? |
| Prevalence | 3 | 2020 | 25773 | 0.03 | Why? |
| Molecular Structure | 1 | 2017 | 1539 | 0.03 | Why? |
| Infant | 3 | 2020 | 30274 | 0.03 | Why? |
| Occupations | 1 | 2018 | 733 | 0.03 | Why? |
| Recombination, Genetic | 1 | 2018 | 1265 | 0.03 | Why? |
| Cell Differentiation | 1 | 2017 | 1338 | 0.03 | Why? |
| Temperature | 1 | 2021 | 2305 | 0.03 | Why? |
| Rats | 1 | 2019 | 2764 | 0.03 | Why? |
| History, 21st Century | 1 | 2018 | 1849 | 0.03 | Why? |
| Structure-Activity Relationship | 1 | 2017 | 2219 | 0.03 | Why? |
| Reagent Kits, Diagnostic | 1 | 2021 | 2149 | 0.03 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2021 | 1261 | 0.03 | Why? |
| Dengue Virus | 1 | 2018 | 910 | 0.03 | Why? |
| Sensitivity and Specificity | 2 | 2021 | 22971 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 37182 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2020 | 5542 | 0.02 | Why? |
| Fatal Outcome | 1 | 2018 | 3438 | 0.02 | Why? |
| Malaria | 1 | 2018 | 1097 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2017 | 3776 | 0.02 | Why? |
| Infant, Newborn | 2 | 2020 | 23105 | 0.02 | Why? |
| ROC Curve | 1 | 2020 | 6024 | 0.02 | Why? |
| Drug Combinations | 1 | 2017 | 3852 | 0.02 | Why? |
| Virus Replication | 2 | 2020 | 14331 | 0.02 | Why? |
| Iran | 1 | 2020 | 5467 | 0.02 | Why? |
| Skin | 1 | 2019 | 2096 | 0.02 | Why? |
| Cells, Cultured | 1 | 2017 | 5835 | 0.02 | Why? |
| Kidney | 1 | 2020 | 3648 | 0.02 | Why? |
| Acute Disease | 1 | 2018 | 6029 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2020 | 4849 | 0.02 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.02 | Why? |
| Diagnostic Tests, Routine | 1 | 2017 | 2643 | 0.02 | Why? |
| Aerosols | 1 | 2021 | 5393 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2020 | 9537 | 0.02 | Why? |
| Zoonoses | 1 | 2019 | 3034 | 0.02 | Why? |
| Family | 1 | 2018 | 2909 | 0.02 | Why? |
| Tuberculosis | 1 | 2018 | 2895 | 0.01 | Why? |
| Specimen Handling | 1 | 2020 | 6190 | 0.01 | Why? |
| Lung | 2 | 2021 | 31049 | 0.01 | Why? |
| Population Surveillance | 1 | 2018 | 4967 | 0.01 | Why? |
| Age Factors | 1 | 2018 | 21039 | 0.01 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| Italy | 1 | 2020 | 38444 | 0.01 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.01 | Why? |
| Pregnancy | 1 | 2017 | 23879 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| Pregnancy Complications, Infectious | 1 | 2017 | 11559 | 0.01 | Why? |
| Risk Factors | 1 | 2019 | 71621 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2019 | 88759 | 0.01 | Why? |
| Health Personnel | 1 | 2017 | 29646 | 0.01 | Why? |